Assessment of the incidence and etiology of nosocomial diarrhea in a medical ward in Iraq.

Ammar Jabbar Hamad, Aseel Jassim Albdairi, Samer Nema Yassen Alkemawy, Safaa Ali Khudair, Noor Rafea Abdulhadi
Author Information
  1. Ammar Jabbar Hamad: Department of Medicine, College of Medicine, University of Kufa, Al-Najaf, Iraq.
  2. Aseel Jassim Albdairi: Department of Physiology, College of Medicine, University of Kufa, Al-Najaf, Iraq.
  3. Samer Nema Yassen Alkemawy: Department of Medicine, College of Medicine, University of Kufa, Al-Najaf, Iraq.
  4. Safaa Ali Khudair: Department of Medicine, College of Medicine, University of Kufa, Al-Najaf, Iraq.
  5. Noor Rafea Abdulhadi: Department of Medicine, College of Medicine, University of Kufa, Al-Najaf, Iraq.

Abstract

This study aimed to detect the incidence, etiology, risk factors, and severity of nosocomial diarrhea among adult inpatients in a medical ward in Iraq. The study was conducted among patients admitted to the medical ward from June 1, 2019, to January 31, 2020, in AL-Sader medical city. The surveillance for nosocomial diarrhea was performed by monitoring every patient in the ward 3 times/week. 1050 patients were admitted to the medical ward in AL-Sader medical city. Of these, 52 patients (mean age 58±12.91 years, range 32 to 80) developed new-onset diarrhea during hospitalization. There was a significant relationship between the severity of diarrhea and age, residence, antibiotic use, including number and duration of antibiotics, immunosuppressive agents (steroids/chemotherapy), duration of hospital stay, level of consciousness, and enema use. Nosocomial diarrhea is a significant clinical problem that complicates about 5% of all admission in the medical ward. Various microorganisms account for nosocomial diarrhea, including , , and . Several risk factors associated with the severe form of nosocomial diarrhea include old age, antibiotic use, immunosuppressive use, and length of hospital stay.

Keywords

References

  1. Braz J Infect Dis. 2006 Dec;10(6):384-9 [PMID: 17420910]
  2. J Hosp Infect. 2005 Jul;60(3):283-5 [PMID: 15949620]
  3. Ann Ig. 2019 Jul-Aug;31(4):365-373 [PMID: 31268121]
  4. N Engl J Med. 2018 Nov 22;379(21):2015-2026 [PMID: 30462939]
  5. World J Gastrointest Pathophysiol. 2019 Sep 10;10(2):17-28 [PMID: 31559106]
  6. Ther Adv Med Oncol. 2010 Jan;2(1):51-63 [PMID: 21789126]
  7. Ann Clin Microbiol Antimicrob. 2011 Oct 22;10:36 [PMID: 22018286]
  8. Infect Control Hosp Epidemiol. 2007 Oct;28(10):1142-7 [PMID: 17828690]
  9. Lancet. 2011 Jan 15;377(9761):228-41 [PMID: 21146207]
  10. Curr Opin Gastroenterol. 2012 Jan;28(1):63-9 [PMID: 22080827]
  11. PLoS One. 2014 Oct 13;9(10):e109324 [PMID: 25310563]
  12. Lancet. 2018 Jul 14;392(10142):175-186 [PMID: 30025810]
  13. Clin Infect Dis. 2009 Jan 1;48(1):22-4 [PMID: 19067618]
  14. N Engl J Med. 2017 Jan 26;376(4):305-317 [PMID: 28121498]
  15. Infect Control Hosp Epidemiol. 1991 Jun;12(6):349-55 [PMID: 1906497]
  16. Ann Oncol. 2007 Jan;18(1):183-189 [PMID: 17023562]
  17. Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S41-50 [PMID: 2406855]
  18. PLoS One. 2014 Feb 19;9(2):e89085 [PMID: 24586516]
  19. Ann Intern Med. 2016 Nov 1;165(9):609-616 [PMID: 27547925]
  20. Ann Pharmacother. 2006 Jun;40(6):1030-4 [PMID: 16684806]
  21. Eur J Clin Microbiol Infect Dis. 2000 Jan;19(1):9-15 [PMID: 11699546]
  22. Clin Infect Dis. 2012 Oct;55(7):982-9 [PMID: 22700831]
  23. Am J Infect Control. 2009 Aug;37(6):517-8 [PMID: 19643282]
  24. Dtsch Med Wochenschr. 2001 Dec 14;126(50):1431-4 [PMID: 11743680]
  25. N Engl J Med. 2018 Nov 22;379(21):2002-2014 [PMID: 30462938]
  26. Bratisl Lek Listy. 2011;112(5):273-7 [PMID: 21682082]
  27. Infect Dis Ther. 2016 Sep;5(3):207-30 [PMID: 27470257]
  28. Gastroenterol Clin North Am. 1993 Sep;22(3):563-77 [PMID: 8406731]
  29. J Infect Dis. 1990 Sep;162(3):678-84 [PMID: 2387993]
  30. Am J Trop Med Hyg. 2014 Jul;91(1):165-172 [PMID: 24778198]
  31. Ochsner J. 2009 Spring;9(1):27-31 [PMID: 21603406]
  32. J Hosp Infect. 2008 Apr;68(4):285-92 [PMID: 18329137]

MeSH Term

Adult
Aged
Aged, 80 and over
Cross Infection
Diarrhea
Humans
Incidence
Iraq
Middle Aged
Risk Factors

Word Cloud

Created with Highcharts 10.0.0diarrheamedicalwardnosocomialusepatientsagestudyincidenceetiologyriskfactorsseverityamongIraqadmittedAL-SadercitysignificantantibioticincludingdurationimmunosuppressivehospitalstayaimeddetectadultinpatientsconductedJune12019January312020surveillanceperformedmonitoringeverypatient3times/week105052mean58±1291yearsrange3280developednew-onsethospitalizationrelationshipresidencenumberantibioticsagentssteroids/chemotherapylevelconsciousnessenemaNosocomialclinicalproblemcomplicates5%admissionVariousmicroorganismsaccountSeveralassociatedsevereformincludeoldlengthAssessmentgastrointestinalparasitesinfections

Similar Articles

Cited By (1)